Clinical aspects of systemic sclerosis (scleroderma).
Open Access
- 1 November 1991
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 50 (Suppl 4) , 854-861
- https://doi.org/10.1136/ard.50.suppl_4.854
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Prevalence of Raynaud phenomenon in the general population: A preliminary study by questionnairePublished by Elsevier ,2004
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Continuous Ambulatory Peritoneal Dialysis in SclerodermaNephron, 1990
- Effect of lymphotoxin and tumor necrosis factor on endothelial and connective tissue cell growth and functionClinical Immunology and Immunopathology, 1988
- Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitisPublished by Elsevier ,1987
- Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding geneFEBS Letters, 1987
- Reduced coronary flow and resistance reserve in primary scleroderma myocardial diseaseAmerican Heart Journal, 1986
- Nifedipine and Thallium-201 Myocardial Perfusion in Progressive Systemic SclerosisNew England Journal of Medicine, 1986
- Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captoprilJournal of Molecular Medicine, 1984
- Development of a Scleroderma-like Illness during Therapy with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1980